Class Action

Combivent Respimat Asthma Inhalers

Class Action

Combivent Respimat Asthma Inhalers

In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat asthma inhaler will provide 120 doses when, according to plaintiffs, the inhaler contains far fewer dosages, sometimes less than half the advertised amount. (Ignacuinos et al v. Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-672, D. Conn.)


The Latest

Filters

iFLO AC Cleaner

Ad Alert

iFLO AC Cleaner

Is this device maker blowing hot air when it comes to its clog-free claims?


Show More